13F

RMD RESMED INC

2026Q1 · CUSIP 761152107 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
935
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
292
Δ whales
+6
Inst. holding value
$21.5B
New positions
103
Closed positions
115
Price momentum (1Q)
-20.0%
Put / Call
15/12

Breadth history (34 quarters)

2018Q1: Δ+31 · h=446 2018Q2: Δ+14 · h=460 2018Q3: Δ+34 · h=494 2018Q4: Δ+5 · h=499 2019Q1: Δ-23 · h=476 2019Q2: Δ+7 · h=483 2019Q3: Δ+47 · h=530 2019Q4: Δ+29 · h=559 2020Q1: Δ+25 · h=584 2020Q2: Δ-3 · h=581 2020Q3: Δ+41 · h=622 2020Q4: Δ+40 · h=662 2021Q1: Δ+0 · h=662 2021Q2: Δ+1 · h=663 2021Q3: Δ+20 · h=683 2021Q4: Δ+36 · h=719 2022Q1: Δ-40 · h=679 2022Q2: Δ-6 · h=673 2022Q3: Δ-7 · h=666 2022Q4: Δ+67 · h=733 2023Q1: Δ-54 · h=679 2023Q2: Δ+51 · h=730 2023Q3: Δ-70 · h=660 2023Q4: Δ+31 · h=691 2024Q1: Δ+28 · h=719 2024Q2: Δ+58 · h=777 2024Q3: Δ+26 · h=803 2024Q4: Δ+66 · h=869 2025Q1: Δ+16 · h=885 2025Q2: Δ+33 · h=918 2025Q3: Δ+30 · h=948 2025Q4: Δ-1 · h=947 2026Q1: Δ-12 · h=935 2018Q1: holders=446 2018Q2: holders=460 2018Q3: holders=494 2018Q4: holders=499 2019Q1: holders=476 2019Q2: holders=483 2019Q3: holders=530 2019Q4: holders=559 2020Q1: holders=584 2020Q2: holders=581 2020Q3: holders=622 2020Q4: holders=662 2021Q1: holders=662 2021Q2: holders=663 2021Q3: holders=683 2021Q4: holders=719 2022Q1: holders=679 2022Q2: holders=673 2022Q3: holders=666 2022Q4: holders=733 2023Q1: holders=679 2023Q2: holders=730 2023Q3: holders=660 2023Q4: holders=691 2024Q1: holders=719 2024Q2: holders=777 2024Q3: holders=803 2024Q4: holders=869 2025Q1: holders=885 2025Q2: holders=918 2025Q3: holders=948 2025Q4: holders=947 2026Q1: holders=935 -70 -35 +0 +35 +70 401699996 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 21 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q3 Top 10% +5.0% -13.8%
2025Q2 Top 8% -14.4% -9.1%
2025Q1 Top 15% +13.1% -3.0%
2024Q4 Top 7% +10.1% +24.6%
2024Q3 Top 12% -3.0% +3.0%
2024Q2 Top 2% +1.8% +3.4%
2024Q1 Top 10% +6.1% +7.9%
2023Q4 Top 17% +21.4% +28.8%

Options Sentiment

Put holders
15
QoQ: -3
Call holders
12
QoQ: -4

See methodology →

Fundamentals

PE (TTM)
18.7
EPS (TTM)
$10.37
EPS YoY
+16.5%
Revenue (TTM)
$5.5B
Revenue YoY
+10.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $0.9B 2022-09-30: $1.0B 2022-12-31: $1.0B 2023-03-31: $1.1B 2023-06-30: $1.1B 2023-09-30: $1.1B 2023-12-31: $1.2B 2024-03-31: $1.2B 2024-06-30: $1.2B 2024-09-30: $1.2B 2024-12-31: $1.3B 2025-03-31: $1.3B 2025-06-30: $1.3B 2025-09-30: $1.3B 2025-12-31: $1.4B 2026-03-31: $1.4B 2022-06-30: EPS 1.32 2022-09-30: EPS 1.43 2022-12-31: EPS 1.53 2023-03-31: EPS 1.58 2023-06-30: EPS 1.55 2023-09-30: EPS 1.49 2023-12-31: EPS 1.42 2024-03-31: EPS 2.04 2024-06-30: EPS 1.97 2024-09-30: EPS 2.11 2024-12-31: EPS 2.34 2025-03-31: EPS 2.48 2025-06-30: EPS 2.58 2025-09-30: EPS 2.37 2025-12-31: EPS 2.68 2026-03-31: EPS 2.74 0B 0.7B 1.4B $B 0.00 1.51 3.01 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 28 2023-03-31: PE 37.12023-06-30: PE 27.82023-09-30: PE 23.72023-12-31: PE 29.32024-03-31: PE 332024-06-30: PE 32.42024-09-30: PE 30.72024-12-31: PE 27.22025-03-31: PE 282025-06-30: PE 29.72025-09-30: PE 24.92025-12-31: PE 24.92026-03-31: PE 19.5 18 28 39 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)